speb/financial-data huggingface dataset:
Financial ratios for ASC.L — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: -217215189.8734177
Buffett classification: The Gruesome
Stock price: 0.04227848101265822
Shares outstanding: 119648735
Book value: 406075949.36708856
P/B ratio: 0.012457193731296758
Market cap (USD): 5058566.770886075
Debt to equity: 2.2811720698254367
Current ratio: 1.1800759953741946
Quick ratio: 0.49991739633239707
Buyback yield (%): 0
Retained earnings: -25696202.53164557
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASC.L — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: -352972972.972973
Buffett classification: The Gruesome
Stock price: 0.037567567567567565
Shares outstanding: 119648735
Book value: 287027027.0270269
P/B ratio: 0.015660239326742004
Market cap (USD): 4494911.936486486
Debt to equity: 3.427966101694917
Current ratio: 1.0236334829680487
Quick ratio: 0.4924742540269343
Buyback yield (%): 0
Retained earnings: -159459459.45945945
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASC.L — annual report dated 2025-08-31
Total revenue: 3348378378.3783784
Gross profit: 1576621621.6216216
Operating income: -47297297.2972973
Net income: -403243243.2432433
Capital expenditures: 10675675.675675675
Operating cash flow: 215000000
Depreciation & amortization: 225540540.54054055
Net tangible assets: -352972972.972973
Owner earnings: -188378378.3783784
Buffett classification: The Gruesome
Stock price: 0.037567567567567565
Shares outstanding: 119648735
Book value: 287027027.0270269
P/B ratio: 0.015660239326742004
Market cap (USD): 4494911.936486486
Debt to equity: 3.427966101694917
Current ratio: 1.0236334829680487
Quick ratio: 0.4924742540269343
Interest coverage ratio: -0.4723346828609987
COGS to revenue (%): 52.91387521188151
SG&A to revenue (%): 48.42602308499475
Free cash flow (dilution-adjusted): 93918918.91891892
Buyback yield (%): 0
Retained earnings: -159459459.45945945
Inventory turnover: 3.25901068854089
Receivables turnover: 495.56
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.826391166502679
FCF margin (%): 2.8049075793042215
Revenue growth (%): -12.424545131544924
Rule of 40 score: -9.619637552240704
Financial ratios for BIGG.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8188976377952756
Shares outstanding: 355780820
Market cap (USD): 291348073.0708661
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIGG.V — annual report dated 2022-12-31
Total revenue: 5494720.5882352935
Gross profit: 5226684.558823529
Operating income: -13522350.735294117
Net income: -32465574.999999996
Capital expenditures: 316744.1176470588
Operating cash flow: -13539005.147058822
Depreciation & amortization: 280784.5588235294
Net tangible assets: 16122239.705882352
Owner earnings: -32501534.558823526
Return on net tangible assets (%): -201.59441338020198
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
Shares outstanding: 355780820
Book value: 17000004.411764707
P/B ratio: 3.385456751179043
Market cap (USD): 57552779.70588235
Debt to equity: 0.0015531137837940005
Current ratio: 1.2170125020109945
Quick ratio: 0.32279931701058895
COGS to revenue (%): 4.878064773405488
R&D to revenue (%): 12.20863074448468
SG&A to revenue (%): 294.35055307099594
Free cash flow (dilution-adjusted): -15154607.352941176
Buyback yield (%): 0
Retained earnings: -64850746.32352941
Inventory turnover: 0.009207228966300132
Receivables turnover: 3.386751604134356
Capitalized R&D asset: 670830.1470588235
ROCI (R&D-adjusted, %): -73.97035893430113
FCF margin (%): -275.8030569450355
Rule of 40 score: -275.8030569450355
Financial ratios for BIGG.V — annual report dated 2023-12-31
Total revenue: 4920225
Gross profit: 4721472.727272727
Operating income: -11682889.393939393
Net income: -8384075
Capital expenditures: 46102.27272727273
Operating cash flow: -7667762.878787878
Depreciation & amortization: 237771.2121212121
Net tangible assets: 11258706.06060606
Owner earnings: -8192406.060606061
Return on net tangible assets (%): -72.76507634630494
Buffett classification: The Gruesome
Stock price: 0.25757575757575757
Shares outstanding: 355780820
Book value: 24650641.666666657
P/B ratio: 3.7175711481110576
Market cap (USD): 91640514.24242423
Debt to equity: 0.0017999101197408753
Current ratio: 1.1315798146537341
Quick ratio: 0.1361253698788721
COGS to revenue (%): 4.039495606954412
R&D to revenue (%): 20.007276705903294
SG&A to revenue (%): 296.45851068956716
Free cash flow (dilution-adjusted): -9828025.757575758
Buyback yield (%): 0
Retained earnings: -75199995.45454545
Inventory turnover: 0.002877048083066222
Receivables turnover: 4.067376304032245
Capitalized R&D asset: 1433859.228832442
ROCI (R&D-adjusted, %): -43.07295762482628
Rosenberg metric: -0.7531143818831704
FCF margin (%): -199.7474862953576
Revenue growth (%): -10.455410407316105
Rule of 40 score: -210.20289670267368
Financial ratios for BIGG.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11851851851851851
Shares outstanding: 355780820
Market cap (USD): 42166615.7037037
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIGG.V — annual report dated 2024-12-31
Total revenue: 8692800.699300699
Gross profit: 8302485.314685315
Operating income: -12443658.741258742
Net income: -18062706.993006993
Capital expenditures: 86063.63636363637
Operating cash flow: -8662555.244755246
Depreciation & amortization: 257685.3146853147
Net tangible assets: 11269048.951048952
Owner earnings: -17891085.314685315
Return on net tangible assets (%): -158.76304550988723
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 355780820
Book value: 12261419.58041957
P/B ratio: 3.449488183699742
Market cap (USD): 42295621.958041966
Debt to equity: 0.0025980632868004335
Current ratio: 1.0423115283702797
Quick ratio: 0.11594958866769972
COGS to revenue (%): 4.490099314560196
R&D to revenue (%): 20.547265822815362
SG&A to revenue (%): 142.76061574946877
Free cash flow (dilution-adjusted): -9046967.132867133
Buyback yield (%): 0
Retained earnings: -87478087.41258742
Inventory turnover: 0.002814080789026606
Receivables turnover: 7.171102729594956
Capitalized R&D asset: 2667056.845965309
ROCI (R&D-adjusted, %): -78.97903412611849
Rosenberg metric: 3.6377504712782525
FCF margin (%): -104.07425001236858
Revenue growth (%): 76.67486139964532
Rule of 40 score: -27.399388612723257
Financial ratios for BIGG.V — quarterly report dated 2024-12-31
Total revenue: 2939229.3706293707
Gross profit: 2754105.5944055947
Operating income: -4754406.293706294
Net income: -7974323.076923077
Capital expenditures: 7086.713286713287
Operating cash flow: -1408409.090909091
Depreciation & amortization: 58174.82517482518
Net tangible assets: 11269048.951048952
Owner earnings: -7923234.965034965
Return on net tangible assets (%): -70.30970403493943
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 355780820
Book value: 12261419.58041957
P/B ratio: 3.449488183699742
Market cap (USD): 42295621.958041966
Debt to equity: 0.0025980632868004335
Current ratio: 1.0423115283702797
Quick ratio: 0.11594958866769972
COGS to revenue (%): 6.298378005937525
R&D to revenue (%): 13.384246572409209
SG&A to revenue (%): 45.85148859246203
Free cash flow (dilution-adjusted): -1435950.3496503497
Buyback yield (%): 0
Retained earnings: -87478087.41258742
Inventory turnover: 0.0013346982537640285
Receivables turnover: 2.4247094223984162
Capitalized R&D asset: 393393.7062937063
ROCI (R&D-adjusted, %): -35.446861492829015
FCF margin (%): -48.854654352575174
Rule of 40 score: -48.854654352575174
Financial ratios for BIGG.V — quarterly report dated 2025-03-31
Total revenue: 2858678.321678322
Gross profit: 2747044.755244755
Operating income: -2909430.7692307695
Net income: -2526642.6573426574
Capital expenditures: 10325.874125874127
Operating cash flow: 1616804.895104895
Depreciation & amortization: 59767.83216783217
Net tangible assets: 8183626.573426574
Owner earnings: -2477200.6993006994
Return on net tangible assets (%): -30.270206944003657
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 355780820
Book value: 9122923.776223764
P/B ratio: 2.727171489388029
Market cap (USD): 24879777.622377623
Debt to equity: 0.0032365252797053744
Current ratio: 1.0374269542941172
Quick ratio: 0.13332557980758533
COGS to revenue (%): 3.905076188076548
R&D to revenue (%): 31.01350078646546
SG&A to revenue (%): 100.76682216585002
Free cash flow (dilution-adjusted): 1590639.160839161
Buyback yield (%): 0
Retained earnings: -90008777.62237762
Inventory turnover: 0.0009591074151158755
Receivables turnover: 1.2289808974644194
Capitalized R&D asset: 1150150.0069930071
ROCI (R&D-adjusted, %): -23.808199530022584
Rosenberg metric: -0.017948531071740034
FCF margin (%): 55.64246766685177
Revenue growth (%): -2.7405499467297667
Rule of 40 score: 52.90191772012201
Financial ratios for BIGG.V — quarterly report dated 2025-06-30
Total revenue: 1942268.613138686
Gross profit: 1912677.3722627736
Operating income: -1514767.8832116788
Net income: -85567.15328467153
Capital expenditures: 4956.934306569343
Operating cash flow: -4293699.270072992
Depreciation & amortization: 62426.27737226277
Net tangible assets: 8832935.766423358
Owner earnings: -28097.810218978102
Return on net tangible assets (%): -0.3181027346059316
Buffett classification: The Gruesome
Stock price: 0.08029197080291971
Shares outstanding: 355780820
Book value: 9791694.160583943
P/B ratio: 2.9174055830574708
Market cap (USD): 28566343.211678833
Debt to equity: 0.0027489408757802396
Current ratio: 1.0394565476745197
Quick ratio: 0.09815899394203667
COGS to revenue (%): 1.5235400848131542
R&D to revenue (%): 18.350878722601458
SG&A to revenue (%): 146.09231134635243
Free cash flow (dilution-adjusted): -4312372.2627737215
Buyback yield (%): 0
Retained earnings: -94036387.59124087
Inventory turnover: 0.00021488676911684035
Receivables turnover: 1.2073298937685375
Capitalized R&D asset: 1080249.3506712266
ROCI (R&D-adjusted, %): -15.654724287025596
Rosenberg metric: -0.9411118419442072
FCF margin (%): -222.027593588354
Revenue growth (%): -32.057111903434254
Rule of 40 score: -254.08470549178824
Financial ratios for BIGG.V — quarterly report dated 2025-09-30
Total revenue: 2365683.45323741
Gross profit: 2325772.661870504
Operating income: -1221552.5179856117
Net income: 1018912.2302158274
Capital expenditures: 1381.294964028777
Operating cash flow: -33814.388489208635
Depreciation & amortization: 55723.74100719425
Net tangible assets: 9763166.906474821
Owner earnings: 1073254.6762589929
Return on net tangible assets (%): 10.99289489302106
Buffett classification: The Gruesome
Stock price: 0.08633093525179857
P/E ratio: 7.5361964515691735
Shares outstanding: 355780820
Book value: 10687017.266187072
P/B ratio: 2.8740377385214333
Market cap (USD): 30714890.9352518
Debt to equity: 0.0021152539415470384
Current ratio: 1.0401544437308445
Quick ratio: 0.1052409141574872
Effective tax rate (%): -0.01398216215071076
COGS to revenue (%): 1.6870723474135572
R&D to revenue (%): 16.201623939421587
SG&A to revenue (%): 120.22653042605602
Free cash flow (dilution-adjusted): -200571.22302158273
Buyback yield (%): 0
Retained earnings: -91664433.81294964
Inventory turnover: 0.00023289924020506217
Receivables turnover: 0.6006363095362042
Capitalized R&D asset: 914652.9401718379
ROCI (R&D-adjusted, %): -11.89067368073857
Rosenberg metric: 1.1590017341031957
FCF margin (%): -8.478362679804153
Revenue growth (%): 21.800014541474276
Rule of 40 score: 13.321651861670123
Financial ratios for BIGG.V — annual report dated 2025-12-31
Total revenue: 9387559.854014598
Gross profit: 9166501.459854014
Operating income: -1125773.722627737
Net income: -929028.4671532846
Capital expenditures: 18418.24817518248
Operating cash flow: -6590794.160583941
Depreciation & amortization: 225772.9927007299
Net tangible assets: 10371983.21167883
Owner earnings: -721673.7226277372
Return on net tangible assets (%): -6.957914488476362
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
Shares outstanding: 355780820
Book value: 11269091.2408759
P/B ratio: 1.382688401288844
Market cap (USD): 15581641.751824817
Debt to equity: 0.0016749516068595373
Current ratio: 1.071394029086774
Quick ratio: 0.10764197801464431
COGS to revenue (%): 2.354801435072056
R&D to revenue (%): 19.992719048823503
SG&A to revenue (%): 121.93503173986198
Free cash flow (dilution-adjusted): -6961128.467153284
Buyback yield (%): 0
Retained earnings: -92242445.25547445
Inventory turnover: 0.0018293104239036856
Receivables turnover: 12.955349677752102
Capitalized R&D asset: 3398390.4881323054
ROCI (R&D-adjusted, %): -5.440068271378486
Rosenberg metric: 0.4837356509516751
FCF margin (%): -74.15269330268346
Revenue growth (%): 7.9923511276381785
Rule of 40 score: -66.16034217504529
Financial ratios for BIGG.V — quarterly report dated 2025-12-31
Total revenue: 2061196.3503649633
Gross profit: 2026745.2554744524
Operating income: 2977150.3649635036
Net income: 760155.4744525547
Capital expenditures: 1281.7518248175181
Operating cash flow: -3950400.729927007
Depreciation & amortization: 44424.087591240874
Net tangible assets: 10371983.21167883
Owner earnings: 803297.8102189781
Return on net tangible assets (%): 7.744881512288475
Capex to operating income (%): 0.043052975754996205
Buffett classification: The Great
Stock price: 0.0437956204379562
P/E ratio: 5.124491724224683
Shares outstanding: 355780820
Book value: 11269091.2408759
P/B ratio: 1.382688401288844
Market cap (USD): 15581641.751824817
Debt to equity: 0.0016749516068595373
Current ratio: 1.071394029086774
Quick ratio: 0.10764197801464431
Effective tax rate (%): -0.0018244775752500975
COGS to revenue (%): 1.6714125699092621
R&D to revenue (%): 10.000322256332602
SG&A to revenue (%): 131.80510645259875
Free cash flow (dilution-adjusted): -4105559.1240875907
Buyback yield (%): 0
Retained earnings: -92242445.25547445
Inventory turnover: 0.0002850909472920791
Receivables turnover: 2.8445644969245927
Capitalized R&D asset: 580543.0069841937
ROCI (R&D-adjusted, %): 24.19781305444011
Rosenberg metric: -0.7801817990354184
FCF margin (%): -199.1833103799473
Revenue growth (%): -12.870999391561025
Rule of 40 score: -212.05430977150831
Financial ratios for BKE — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.97
Shares outstanding: 51518086
Market cap (USD): 1337924693.4199998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKE — annual report dated 2023-01-31
Total revenue: 1345187000
Gross profit: 676003000
Operating income: 328132000
Net income: 254626000
Capital expenditures: 30360000
Operating cash flow: 242382000
Depreciation & amortization: 18855000
Net tangible assets: 376314000
Owner earnings: 243121000
Return on net tangible assets (%): 64.60588763638876
Capex to operating income (%): 9.25237404459181
Buffett classification: The Great
Stock price: 33.43
P/E ratio: 6.763840357936738
Shares outstanding: 51518086
Book value: 376314000
P/B ratio: 4.576629131469995
Market cap (USD): 1722249614.98
Debt to equity: 0.8072646779019649
Current ratio: 1.8728118101423181
Quick ratio: 1.3192268727631469
Effective tax rate (%): 24.00494245738026
COGS to revenue (%): 49.74654081551487
SG&A to revenue (%): 25.860419406372497
Free cash flow (dilution-adjusted): 212022000
Buyback yield (%): 0
Retained earnings: 196849000
Inventory turnover: 5.3477392235523515
Receivables turnover: 106.35570841239722
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 53.65702100939275
FCF margin (%): 15.761526092654776
Rule of 40 score: 15.761526092654776
Financial ratios for BKE — annual report dated 2024-01-31
Total revenue: 1261102000
Gross profit: 619065000
Operating income: 271059000
Net income: 219919000
Capital expenditures: 37270000
Operating cash flow: 254644000
Depreciation & amortization: 20830000
Net tangible assets: 413220000
Owner earnings: 203479000
Return on net tangible assets (%): 49.24229224142104
Capex to operating income (%): 13.749774034435308
Buffett classification: The Great
Stock price: 31.18
P/E ratio: 7.304207101159973
Shares outstanding: 51518086
Book value: 413220000
P/B ratio: 3.887357633899618
Market cap (USD): 1606333921.48
Debt to equity: 0.7632883209912396
Current ratio: 2.0060689256556605
Quick ratio: 1.4357976302290296
Effective tax rate (%): 23.96002973566378
COGS to revenue (%): 50.91079072113121
SG&A to revenue (%): 27.5953887948794
Free cash flow (dilution-adjusted): 217370000
Buyback yield (%): 0
Retained earnings: 220030000
Inventory turnover: 5.083830865468366
Receivables turnover: 145.0042543405772
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.556202252099936
FCF margin (%): 17.236512193303952
Revenue growth (%): -6.250803791591801
Rule of 40 score: 10.98570840171215
Financial ratios for BKE — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.65
Shares outstanding: 51518086
Market cap (USD): 1888137851.8999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKE — annual report dated 2025-01-31
Total revenue: 1217689000
Gross profit: 592787000
Operating income: 241364000
Net income: 195468000
Capital expenditures: 42275000
Operating cash flow: 242014000
Depreciation & amortization: 22993000
Net tangible assets: 423804000
Owner earnings: 176186000
Return on net tangible assets (%): 41.5725193721626
Capex to operating income (%): 17.51503952536418
Buffett classification: The Great
Stock price: 43.39
P/E ratio: 11.435988251478502
Shares outstanding: 51518086
Book value: 423804000
P/B ratio: 5.27453669984238
Market cap (USD): 2235369751.54
Debt to equity: 0.7698440788666459
Current ratio: 2.053030869622123
Quick ratio: 1.4884168801301347
Effective tax rate (%): 24.171667759342377
COGS to revenue (%): 51.31868646263536
SG&A to revenue (%): 28.859832026075622
Free cash flow (dilution-adjusted): 199739000
Buyback yield (%): 0
Retained earnings: 217479000
Inventory turnover: 5.173500898260603
Receivables turnover: 180.1848179934892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.51799880155769
FCF margin (%): 16.403120993948374
Revenue growth (%): -3.4424653993094925
Rule of 40 score: 12.960655594638881
Financial ratios for BKE — quarterly report dated 2025-01-31
Total revenue: 379199000
Gross profit: 199485000
Operating income: 96225000
Net income: 77198000
Capital expenditures: 9821000
Operating cash flow: 120772000
Depreciation & amortization: 6394000
Net tangible assets: 423804000
Owner earnings: 73771000
Return on net tangible assets (%): 17.406867325461768
Capex to operating income (%): 10.20628734736295
Buffett classification: The Great
Stock price: 43.39
P/E ratio: 7.239079223360709
Shares outstanding: 51518086
Book value: 423804000
P/B ratio: 5.27453669984238
Market cap (USD): 2235369751.54
Debt to equity: 0.7698440788666459
Current ratio: 2.053030869622123
Quick ratio: 1.4884168801301347
Effective tax rate (%): 23.663080452495848
COGS to revenue (%): 47.393057471143116
SG&A to revenue (%): 27.231084470159466
Free cash flow (dilution-adjusted): 110951000
Buyback yield (%): 0
Retained earnings: 217479000
Inventory turnover: 1.4878341570838405
Receivables turnover: 56.111127552530334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.761349806432976
FCF margin (%): 29.259307118425948
Rule of 40 score: 29.259307118425948
Financial ratios for BKE — quarterly report dated 2025-04-30
Total revenue: 272121000
Gross profit: 126976000
Operating income: 43546000
Net income: 35193000
Capital expenditures: 11403000
Operating cash flow: 30976000
Depreciation & amortization: 5861000
Net tangible assets: 445273000
Owner earnings: 29651000
Return on net tangible assets (%): 6.659060845818184
Capex to operating income (%): 26.186102053001427
Buffett classification: The Good
Stock price: 32
P/E ratio: 11.710984798113262
Shares outstanding: 51518086
Book value: 445273000
P/B ratio: 3.7023999928133975
Market cap (USD): 1648578752
Debt to equity: 0.8302457144268797
Current ratio: 2.0927069889633443
Quick ratio: 1.484634568661042
Effective tax rate (%): 24.499603115010835
COGS to revenue (%): 53.33840460677419
SG&A to revenue (%): 30.659155302236872
Free cash flow (dilution-adjusted): 19573000
Buyback yield (%): 0
Retained earnings: 234766000
Inventory turnover: 1.096302730465652
Receivables turnover: 34.328371388923934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7327540810953135
FCF margin (%): 7.19275616361839
Revenue growth (%): -28.237943665463256
Rule of 40 score: -21.045187501844865
Financial ratios for BKE — quarterly report dated 2025-07-31
Total revenue: 305737000
Gross profit: 145009000
Operating income: 56341000
Net income: 45006000
Capital expenditures: 12036000
Operating cash flow: 58436000
Depreciation & amortization: 6130000
Net tangible assets: 476155000
Owner earnings: 39100000
Return on net tangible assets (%): 8.211611765076498
Capex to operating income (%): 21.36277311371825
Buffett classification: The Great
Stock price: 45.78
P/E ratio: 14.98438964580011
Shares outstanding: 51518086
Book value: 476155000
P/B ratio: 4.953214766368094
Market cap (USD): 2358497977.08
Debt to equity: 0.7892009954741628
Current ratio: 2.148958415013461
Quick ratio: 1.5282504334492102
Effective tax rate (%): 24.5005116505343
COGS to revenue (%): 52.5706734873437
SG&A to revenue (%): 29.001396625204016
Free cash flow (dilution-adjusted): 46400000
Buyback yield (%): 0
Retained earnings: 261868000
Inventory turnover: 1.1280266131409402
Receivables turnover: 39.68548805815161
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.05075099051657
FCF margin (%): 15.176442497963935
Revenue growth (%): 12.35332811506646
Rule of 40 score: 27.529770613030394
Financial ratios for BKE — quarterly report dated 2025-10-31
Total revenue: 320837000
Gross profit: 153906000
Operating income: 60914000
Net income: 48700000
Capital expenditures: 11060000
Operating cash flow: 49447000
Depreciation & amortization: 6180000
Net tangible assets: 510730000
Owner earnings: 43820000
Return on net tangible assets (%): 8.579875863959431
Capex to operating income (%): 18.15674557572972
Buffett classification: The Great
Stock price: 51.15
P/E ratio: 12.785970193161472
Shares outstanding: 51518086
Book value: 510730000
P/B ratio: 5.159575703209132
Market cap (USD): 2635150098.9
Debt to equity: 0.734047343997807
Current ratio: 2.2054620800248723
Quick ratio: 1.5272879005436717
Effective tax rate (%): 24.499635675860038
COGS to revenue (%): 52.02984693161948
SG&A to revenue (%): 28.984188232653963
Free cash flow (dilution-adjusted): 38387000
Buyback yield (%): 0
Retained earnings: 292664000
Inventory turnover: 1.0069490104295478
Receivables turnover: 39.02177085867186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.30453760552571
FCF margin (%): 11.964642482007998
Revenue growth (%): 4.938885381880505
Rule of 40 score: 16.903527863888502
Financial ratios for BKE — quarterly report dated 2026-01-31
Total revenue: 399140000
Gross profit: 209967000
Operating income: 100643000
Net income: 80845000
Capital expenditures: 5115000
Operating cash flow: 112281000
Depreciation & amortization: 7247000
Net tangible assets: 424643000
Owner earnings: 82977000
Return on net tangible assets (%): 19.540413947716083
Capex to operating income (%): 5.082320678040202
Buffett classification: The Great
Stock price: 46.99
P/E ratio: 11.541855124055992
Shares outstanding: 51518086
Book value: 424643000
P/B ratio: 5.70087075764819
Market cap (USD): 2420834861.14
Debt to equity: 0.9038509995455005
Current ratio: 1.8921357808242327
Quick ratio: 1.3027777191018357
Effective tax rate (%): 23.29114164262942
COGS to revenue (%): 47.39514957157889
SG&A to revenue (%): 27.389888259758482
Free cash flow (dilution-adjusted): 101419000
Buyback yield (%): 0
Retained earnings: 202133000
Inventory turnover: 1.3560399701800665
Receivables turnover: 36.35154826958106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.337724331874673
FCF margin (%): 25.409380167359824
Revenue growth (%): 24.405850946119056
Rule of 40 score: 49.81523111347888
Financial ratios for BKE — annual report dated 2026-01-31
Total revenue: 1297835000
Gross profit: 635858000
Operating income: 261444000
Net income: 209744000
Capital expenditures: 39614000
Operating cash flow: 251140000
Depreciation & amortization: 25418000
Net tangible assets: 424643000
Owner earnings: 195548000
Return on net tangible assets (%): 46.049976097569015
Capex to operating income (%): 15.152001958354369
Buffett classification: The Great
Stock price: 46.99
P/E ratio: 11.541855124055992
Shares outstanding: 51518086
Book value: 424643000
P/B ratio: 5.70087075764819
Market cap (USD): 2420834861.14
Debt to equity: 0.9038509995455005
Current ratio: 1.8921357808242327
Quick ratio: 1.3027777191018357
Effective tax rate (%): 24.038548596800656
COGS to revenue (%): 51.00625272087746
SG&A to revenue (%): 28.849121806701163
Free cash flow (dilution-adjusted): 205779000
Buyback yield (%): 0
Retained earnings: 202133000
Inventory turnover: 4.745218775088886
Receivables turnover: 118.19990892531877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.64789404352654
FCF margin (%): 15.855559450931745
Revenue growth (%): 6.581811940487267
Rule of 40 score: 22.437371391419013
Financial ratios for BYKE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.48661479625478044
Shares outstanding: 52279300
Market cap (USD): 25439880.917842545
Buyback yield (%): 0
Retained earnings: 12557681.656336542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYKE.NS — annual report dated 2023-03-31
Total revenue: 13934908.647990257
Gross profit: 8928745.432399513
Operating income: 1266662.6065773447
Net income: 278757.6126674787
Capital expenditures: 5056711.327649209
Operating cash flow: 7389732.0341047505
Depreciation & amortization: 3614433.617539586
Net tangible assets: 19352302.070645556
Owner earnings: -1163520.097442144
Return on net tangible assets (%): -6.012308474695751
Capex to operating income (%): 399.21533180117893
Buffett classification: The Gruesome
Stock price: 0.3934226552984166
P/E ratio: 73.78403347024381
Shares outstanding: 52279300
Book value: 19428514.007308163
P/B ratio: 1.0586430344289726
Market cap (USD): 20567861.02314251
Debt to equity: 0.5087390546310814
Current ratio: 1.4628693327820794
Quick ratio: 0.9826527360270113
Effective tax rate (%): -89.5477886367401
Interest coverage ratio: 1.039815620281769
COGS to revenue (%): 35.92533931905431
SG&A to revenue (%): 9.469553937919123
Free cash flow (dilution-adjusted): 2333020.7064555422
Buyback yield (%): 0
Retained earnings: 11882971.98538368
Inventory turnover: 2.457317437730931
Receivables turnover: 5.50611948271962
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.904397890401023
FCF margin (%): 16.74227485367849
Rule of 40 score: 16.74227485367849
Financial ratios for BYKE.NS — annual report dated 2024-03-31
Total revenue: 10056193.788224008
Gross profit: 6506775.392732942
Operating income: 1226034.2966782588
Net income: 677155.534236719
Capital expenditures: 910169.0850221849
Operating cash flow: 2497253.8673701882
Depreciation & amortization: 3024835.1121237557
Net tangible assets: 24216524.763161052
Owner earnings: 2791821.5613382896
Return on net tangible assets (%): 11.528580540116547
Capex to operating income (%): 74.2368372147615
Buffett classification: The Good
Stock price: 0.6513915547024952
P/E ratio: 50.290210718197436
Shares outstanding: 52279300
Book value: 24216524.763161052
P/B ratio: 1.406242011965426
Market cap (USD): 34054294.50575816
Debt to equity: 0.29181456421064306
Current ratio: 4.265399661515413
Quick ratio: 3.3437949116333274
Effective tax rate (%): -52.213057307671576
Interest coverage ratio: 1.3650249001989347
COGS to revenue (%): 35.295843240884054
SG&A to revenue (%): 4.450467811291865
Free cash flow (dilution-adjusted): 1587084.7823480032
Buyback yield (%): 0
Retained earnings: 12376208.178438662
Inventory turnover: 1.7821141931638238
Receivables turnover: 4.177036376587086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.110913730280569
FCF margin (%): 15.782161877255282
Revenue growth (%): -27.834519462929176
Rule of 40 score: -12.052357585673894
Financial ratios for BYKE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 26622264.69182991
Buffett classification: The Gruesome
Stock price: 0.8662207357859532
Shares outstanding: 52279300
Book value: 26622264.69182991
P/B ratio: 1.701035364067738
Market cap (USD): 45285413.71237458
Debt to equity: 0.32260940337829597
Current ratio: 4.301013529844614
Quick ratio: 3.5755420800189066
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYKE.NS — quarterly report dated 2025-03-31
Total revenue: 3128910.4512508768
Gross profit: 2145931.7278466215
Operating income: 436965.16249707737
Net income: 89852.70049099835
Capital expenditures: 0
Depreciation & amortization: 803869.5347205985
Net tangible assets: 26260907.17792845
Owner earnings: 893722.2352115968
Return on net tangible assets (%): 3.4032420477946967
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7255222312988681
P/E ratio: 105.53326215983572
Shares outstanding: 52279300
Book value: 26260907.177928448
P/B ratio: 1.4443444062976558
Market cap (USD): 37929794.38674291
Debt to equity: 0.4121462384891456
Current ratio: 3.704926363207698
Quick ratio: 3.1259402024382315
Effective tax rate (%): 45.15875847306457
Interest coverage ratio: 1.311600814092217
COGS to revenue (%): 31.4160069046169
Buyback yield (%): 0
Retained earnings: 12594902.969371054
Inventory turnover: 0.6648428110569928
Receivables turnover: 1.2556685166853547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.239517590286013
Rule of 40 score: 0
Financial ratios for BYKE.NS — annual report dated 2025-03-31
Total revenue: 11297696.983867196
Gross profit: 7673801.730184709
Operating income: 1272106.6167874679
Net income: 537128.8286181903
Capital expenditures: 1573334.1126958148
Operating cash flow: 1120645.3121346738
Depreciation & amortization: 3049134.907645546
Net tangible assets: 26260907.17792845
Owner earnings: 2012929.6235679213
Return on net tangible assets (%): 7.665118382733296
Capex to operating income (%): 123.67942214380238
Buffett classification: The Gruesome
Stock price: 0.7255222312988681
P/E ratio: 70.61582318029838
Shares outstanding: 52279300
Book value: 26260907.177928448
P/B ratio: 1.4443444062976558
Market cap (USD): 37929794.38674291
Debt to equity: 0.4121462384891456
Current ratio: 3.704926363207698
Quick ratio: 3.1259402024382315
Effective tax rate (%): -4.534492173279942
Interest coverage ratio: 1.2274788494077835
COGS to revenue (%): 32.07640688945111
SG&A to revenue (%): 5.171641289107569
Free cash flow (dilution-adjusted): -452688.80056114093
Buyback yield (%): 0
Retained earnings: 12594902.969371054
Inventory turnover: 2.4510405465241316
Receivables turnover: 4.533898503877533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6085222886340307
FCF margin (%): -4.006912215892922
Revenue growth (%): 12.345657032753406
Rule of 40 score: 8.338744816860483
Financial ratios for BYKE.NS — quarterly report dated 2025-06-30
Total revenue: 3138614.5565176695
Gross profit: 2210297.2150713787
Operating income: 562906.6229815119
Net income: 251310.5546454482
Capital expenditures: 0
Depreciation & amortization: 815375.6143224901
Owner earnings: 1066686.1689679383
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9751930727825885
P/E ratio: 50.71654400055874
Shares outstanding: 52279300
Market cap (USD): 50982411.209922776
Effective tax rate (%): 4.218882397538242
Interest coverage ratio: 1.605995860319156
COGS to revenue (%): 29.577296757212203
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.3101432724900513
Rule of 40 score: 0.3101432724900513
Financial ratios for BYKE.NS — quarterly report dated 2025-09-30
Total revenue: 2775749.718151071
Gross profit: 1936685.4565952648
Operating income: 458173.61894024804
Net income: 146617.81285231115
Capital expenditures: 0
Depreciation & amortization: 822987.5986471251
Net tangible assets: 25460586.245772265
Owner earnings: 969605.4114994362
Return on net tangible assets (%): 3.808260352451387
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7375422773393461
P/E ratio: 79.0481560481465
Shares outstanding: 52279300
Book value: 25714092.4464487
P/B ratio: 1.4994965916066014
Market cap (USD): 38558193.979706876
Debt to equity: 0.4515792427351327
Current ratio: 3.1153767351329202
Quick ratio: 2.5837815226485
Effective tax rate (%): 3.9937989074265468
Interest coverage ratio: 1.3388239169823752
COGS to revenue (%): 30.228383202888597
Buyback yield (%): 0
Inventory turnover: 0.5975991649269311
Receivables turnover: 1.157698981055245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2916032756635438
Revenue growth (%): -11.561306169726086
Rule of 40 score: -11.561306169726086
Financial ratios for BYKE.NS — quarterly report dated 2025-12-31
Total revenue: 3055686.7550406596
Gross profit: 2113601.4258661023
Operating income: 490408.82254650776
Net income: 175983.06784003566
Capital expenditures: 0
Depreciation & amortization: 869689.2057480228
Owner earnings: 1045672.2735880584
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5627715272362706
P/E ratio: 44.32493398744261
Shares outstanding: 52279300
Market cap (USD): 29421301.50384316
Effective tax rate (%): -1.4252696456086285
Interest coverage ratio: 1.3983863795184548
COGS to revenue (%): 30.8305596972757
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.085096471740064
Rule of 40 score: 10.085096471740064
Financial ratios for CBT — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 45.34
Shares outstanding: 51621417
Market cap (USD): 2340515046.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBT — annual report dated 2022-09-30
Total revenue: 4321000000
Gross profit: 885000000
Operating income: 572000000
Net income: 243000000
Capital expenditures: 193000000
Operating cash flow: 100000000
Depreciation & amortization: 146000000
Net tangible assets: 706000000
Owner earnings: 196000000
Return on net tangible assets (%): 27.762039660056658
Capex to operating income (%): 33.74125874125874
Buffett classification: The Good
Stock price: 59.06
P/E ratio: 12.546341102962964
Shares outstanding: 51621417
Book value: 1032000000
P/B ratio: 2.9542256666860465
Market cap (USD): 3048760888.02
Debt to equity: 1.4786821705426356
Current ratio: 1.6470588235294117
Quick ratio: 1.0461538461538462
Effective tax rate (%): 30.447761194029848
Interest coverage ratio: 10.214285714285714
COGS to revenue (%): 79.51862994677158
R&D to revenue (%): 1.2728535061328397
SG&A to revenue (%): 5.970840083314047
Free cash flow (dilution-adjusted): -134000000
Buyback yield (%): 1.7384111757751046
Retained earnings: 1284000000
Inventory turnover: 5.174698795180723
Receivables turnover: 5.16866028708134
Capitalized R&D asset: 55000000
ROCI (R&D-adjusted, %): 24.59259259259259
FCF margin (%): -3.101133996760009
Rule of 40 score: -3.101133996760009
Financial ratios for CBT — annual report dated 2023-09-30
Total revenue: 3931000000
Gross profit: 839000000
Operating income: 529000000
Net income: 484000000
Capital expenditures: 237000000
Operating cash flow: 595000000
Depreciation & amortization: 144000000
Net tangible assets: 1070000000
Owner earnings: 391000000
Return on net tangible assets (%): 36.54205607476636
Capex to operating income (%): 44.801512287334596
Buffett classification: The Good
Stock price: 65.41
P/E ratio: 6.976357202417354
Shares outstanding: 51621417
Book value: 1407000000
P/B ratio: 2.399827211066098
Market cap (USD): 3376556885.97
Debt to equity: 0.9665955934612651
Current ratio: 1.9781021897810218
Quick ratio: 1.2664233576642336
Effective tax rate (%): -6.208425720620843
Interest coverage ratio: 5.877777777777778
COGS to revenue (%): 78.65683032307301
R&D to revenue (%): 1.4500127194098194
SG&A to revenue (%): 6.436021368608497
Free cash flow (dilution-adjusted): 331000000
Buyback yield (%): 2.9023648441168515
Retained earnings: 1574000000
Inventory turnover: 5.285470085470085
Receivables turnover: 5.656115107913669
Capitalized R&D asset: 93850000
ROCI (R&D-adjusted, %): 19.078417395436713
Rosenberg metric: -0.8363636363636363
FCF margin (%): 8.42024930043246
Revenue growth (%): -9.025688498032864
Rule of 40 score: -0.6054391976004041
Financial ratios for CBT — annual report dated 2024-09-30
Total revenue: 3994000000
Gross profit: 960000000
Operating income: 614000000
Net income: 424000000
Capital expenditures: 241000000
Operating cash flow: 692000000
Depreciation & amortization: 151000000
Net tangible assets: 1239000000
Owner earnings: 334000000
Return on net tangible assets (%): 26.957223567393058
Capex to operating income (%): 39.25081433224756
Buffett classification: The Good
Stock price: 107.5
P/E ratio: 13.0879771875
Shares outstanding: 51621417
Book value: 1590000000
P/B ratio: 3.49012725
Market cap (USD): 5549302327.5
Debt to equity: 0.7723270440251573
Current ratio: 2.0790155440414506
Quick ratio: 1.3639896373056994
Effective tax rate (%): 20.982986767485823
Interest coverage ratio: 7.580246913580247
COGS to revenue (%): 75.96394591887832
R&D to revenue (%): 1.5773660490736103
SG&A to revenue (%): 7.085628442663997
Free cash flow (dilution-adjusted): 426000000
Buyback yield (%): 3.09948872577442
Retained earnings: 1734000000
Inventory turnover: 5.496376811594203
Receivables turnover: 5.448840381991815
Capitalized R&D asset: 119340000
ROCI (R&D-adjusted, %): 20.064821481467064
Rosenberg metric: 2.1228070175438596
FCF margin (%): 10.665998998497747
Revenue growth (%): 1.6026456372424318
Rule of 40 score: 12.268644635740179
Financial ratios for CBT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 107.5
Shares outstanding: 51621417
Market cap (USD): 5549302327.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.17
Shares outstanding: 51621417
Market cap (USD): 4551460336.89
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBT — quarterly report dated 2025-03-31
Total revenue: 936000000
Gross profit: 241000000
Operating income: 162000000
Net income: 105000000
Capital expenditures: 72000000
Operating cash flow: 73000000
Depreciation & amortization: 38000000
Net tangible assets: 1244000000
Owner earnings: 71000000
Return on net tangible assets (%): 5.707395498392283
Capex to operating income (%): 44.44444444444444
Buffett classification: The Good
Stock price: 80.69
P/E ratio: 9.917457470785713
Shares outstanding: 51621417
Book value: 1590000000
P/B ratio: 2.619705747
Market cap (USD): 4165332137.73
Debt to equity: 0.8106918238993711
Current ratio: 1.9596577017114913
Quick ratio: 1.2982885085574571
Effective tax rate (%): 32.450331125827816
Interest coverage ratio: 8.526315789473685
COGS to revenue (%): 74.25213675213675
R&D to revenue (%): 1.6025641025641024
SG&A to revenue (%): 6.837606837606838
Free cash flow (dilution-adjusted): -32000000
Buyback yield (%): 1.1283613994252522
Retained earnings: 1803000000
Inventory turnover: 1.2846580406654344
Receivables turnover: 1.2665764546684708
Capitalized R&D asset: 15000000
ROCI (R&D-adjusted, %): 5.769875880576988
FCF margin (%): -3.418803418803419
Rule of 40 score: -3.418803418803419
Financial ratios for CBT — quarterly report dated 2025-06-30
Total revenue: 923000000
Gross profit: 244000000
Operating income: 167000000
Net income: 113000000
Capital expenditures: 34000000
Operating cash flow: 249000000
Depreciation & amortization: 39000000
Net tangible assets: 1352000000
Owner earnings: 118000000
Return on net tangible assets (%): 8.727810650887575
Capex to operating income (%): 20.35928143712575
Buffett classification: The Great
Stock price: 73.22
P/E ratio: 17.33816583825688
Shares outstanding: 51621417
Book value: 1683000000
P/B ratio: 2.2458230259893046
Market cap (USD): 3779720152.74
Debt to equity: 0.7219251336898396
Current ratio: 2.1256756756756756
Quick ratio: 1.4081081081081082
Effective tax rate (%): 27.741935483870968
Interest coverage ratio: 8.789473684210526
COGS to revenue (%): 73.56446370530878
R&D to revenue (%): 1.6251354279523293
SG&A to revenue (%): 6.717226435536294
Free cash flow (dilution-adjusted): 210000000
Buyback yield (%): 1.0582794065058796
Retained earnings: 1846000000
Inventory turnover: 1.2787193973634652
Receivables turnover: 1.3396226415094339
Capitalized R&D asset: 25050000
ROCI (R&D-adjusted, %): 5.509200685447062
Rosenberg metric: 0.2
FCF margin (%): 22.75189599133261
Revenue growth (%): -1.3888888888888888
Rule of 40 score: 21.36300710244372
Financial ratios for CBT — annual report dated 2025-09-30
Total revenue: 3713000000
Gross profit: 940000000
Operating income: 621000000
Net income: 376000000
Capital expenditures: 274000000
Operating cash flow: 665000000
Depreciation & amortization: 154000000
Net tangible assets: 1361000000
Owner earnings: 256000000
Return on net tangible assets (%): 18.80969875091844
Capex to operating income (%): 44.12238325281804
Buffett classification: The Good
Stock price: 74.66
P/E ratio: 10.250146258563829
Shares outstanding: 51621417
Book value: 1705000000
P/B ratio: 2.260442811272727
Market cap (USD): 3854054993.22
Debt to equity: 0.7126099706744868
Current ratio: 1.6081504702194358
Quick ratio: 1.0815047021943573
Effective tax rate (%): 34.690265486725664
Interest coverage ratio: 8.171052631578947
COGS to revenue (%): 74.68354430379746
R&D to revenue (%): 1.5890115809318612
SG&A to revenue (%): 7.002423915970914
Free cash flow (dilution-adjusted): 367000000
Buyback yield (%): 4.359045221086447
Retained earnings: 1835000000
Inventory turnover: 5.501984126984127
Receivables turnover: 5.533532041728763
Capitalized R&D asset: 120020000
ROCI (R&D-adjusted, %): 20.83039513949985
Rosenberg metric: -0.31746031746031744
FCF margin (%): 9.884190681389713
Revenue growth (%): -7.035553329994992
Rule of 40 score: 2.8486373513947205
Financial ratios for CBT — quarterly report dated 2025-09-30
Total revenue: 899000000
Gross profit: 220000000
Operating income: 137000000
Net income: 54000000
Capital expenditures: 64000000
Operating cash flow: 219000000
Depreciation & amortization: 40000000
Net tangible assets: 1361000000
Owner earnings: 30000000
Return on net tangible assets (%): 2.2042615723732553
Capex to operating income (%): 46.715328467153284
Buffett classification: The Good
Stock price: 74.66
P/E ratio: 14.169319828014707
Shares outstanding: 51621417
Book value: 1705000000
P/B ratio: 2.260442811272727
Market cap (USD): 3854054993.22
Debt to equity: 0.7126099706744868
Current ratio: 1.6081504702194358
Quick ratio: 1.0815047021943573
Effective tax rate (%): 54.78260869565217
Interest coverage ratio: 6.85
COGS to revenue (%): 75.52836484983315
R&D to revenue (%): 1.668520578420467
SG&A to revenue (%): 7.563959955506118
Free cash flow (dilution-adjusted): 150000000
Buyback yield (%): 1.0119212120379253
Retained earnings: 1835000000
Inventory turnover: 1.3472222222222223
Receivables turnover: 1.3397913561847987
Capitalized R&D asset: 30000000
ROCI (R&D-adjusted, %): 4.74376731301939
Rosenberg metric: -1.6
FCF margin (%): 16.68520578420467
Revenue growth (%): -2.600216684723727
Rule of 40 score: 14.084989099480943
Financial ratios for CBT — quarterly report dated 2025-12-31
Total revenue: 849000000
Gross profit: 211000000
Operating income: 129000000
Net income: 82000000
Capital expenditures: 69000000
Operating cash flow: 126000000
Depreciation & amortization: 41000000
Net tangible assets: 1385000000
Owner earnings: 54000000
Return on net tangible assets (%): 3.898916967509025
Capex to operating income (%): 53.48837209302325
Buffett classification: The Good
Stock price: 65.53
P/E ratio: 9.555795073474576
Shares outstanding: 51621417
Book value: 1729000000
P/B ratio: 1.9564785749045692
Market cap (USD): 3382751456.01
Debt to equity: 0.6512434933487565
Current ratio: 1.6670480549199085
Quick ratio: 1.091533180778032
Effective tax rate (%): 31.35593220338983
Interest coverage ratio: 7.166666666666667
COGS to revenue (%): 75.1472320376914
R&D to revenue (%): 1.5312131919905771
SG&A to revenue (%): 8.12720848056537
Free cash flow (dilution-adjusted): 54000000
Buyback yield (%): 1.5372101875121114
Retained earnings: 1836000000
Inventory turnover: 1.268389662027833
Receivables turnover: 1.3782467532467533
Capitalized R&D asset: 28000000
ROCI (R&D-adjusted, %): 4.3856635749456085
Rosenberg metric: -0.6
FCF margin (%): 6.36042402826855
Revenue growth (%): -5.561735261401557
Rule of 40 score: 0.7986887668669933
Financial ratios for CDM1.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.8977272727272725
Shares outstanding: 1030534551
Market cap (USD): 5047277175.920454
Buyback yield (%): 0
Capitalized R&D asset: 44567000
Rule of 40 score: 0
Financial ratios for CDM1.DE — annual report dated 2022-12-31
Total revenue: 785636000
Gross profit: 67480000
Operating income: 1396000
Net income: -78107000
Capital expenditures: 352354000
Operating cash flow: 25616000
Depreciation & amortization: 111626000
Net tangible assets: 889016000
Owner earnings: -318835000
Return on net tangible assets (%): -35.86380897531653
Capex to operating income (%): 25240.25787965616
Buffett classification: The Gruesome
Stock price: 3.4787234042553195
Shares outstanding: 1030534551
Book value: 889016000
P/B ratio: 4.032486098627524
Market cap (USD): 3584944661.457447
Debt to equity: 0.5933447766969323
Current ratio: 1.3695842450765865
Quick ratio: 0.7095322757111597
Interest coverage ratio: 0.06401027098904122
COGS to revenue (%): 91.41078056504539
R&D to revenue (%): 5.17377004108773
SG&A to revenue (%): 5.022682259977903
Free cash flow (dilution-adjusted): -336768000
Buyback yield (%): 0
Retained earnings: -3017549000
Inventory turnover: 4.960017680901173
Receivables turnover: 24.34269071078887
Capitalized R&D asset: 70506890
ROCI (R&D-adjusted, %): 0.8035358846881091
FCF margin (%): -42.865652795951306
Rule of 40 score: -42.865652795951306
Financial ratios for CDM1.DE — annual report dated 2023-12-31
Total revenue: 821206000
Gross profit: 88488000
Operating income: 15921000
Net income: -103612000
Capital expenditures: 364617000
Operating cash flow: 67288000
Depreciation & amortization: 99822000
Net tangible assets: 1023903000
Owner earnings: -368407000
Return on net tangible assets (%): -35.98065441745947
Capex to operating income (%): 2290.16393442623
Buffett classification: The Gruesome
Stock price: 3.344444444444444
Shares outstanding: 1030534551
Book value: 1023903000
P/B ratio: 3.3661055333366536
Market cap (USD): 3446565553.8999996
Debt to equity: 0.5423218800999704
Current ratio: 0.9228004267764224
Quick ratio: 0.38393994744711046
Interest coverage ratio: 0.6032967032967033
COGS to revenue (%): 89.22462816881513
R&D to revenue (%): 6.653141842607092
SG&A to revenue (%): 5.06632927669793
Free cash flow (dilution-adjusted): -308690000
Buyback yield (%): 0
Retained earnings: -3121161000
Inventory turnover: 4.695074361948213
Receivables turnover: 26.99559500328731
Capitalized R&D asset: 96576600
ROCI (R&D-adjusted, %): 1.268152676534742
Rosenberg metric: 0.5168401112013187
FCF margin (%): -37.58983738550376
Revenue growth (%): 4.527542016913685
Rule of 40 score: -33.06229536859008
Financial ratios for CDM1.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.822222222222222
Shares outstanding: 1030534551
Market cap (USD): 7030535714.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CDM1.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.71875
Shares outstanding: 1030534551
Market cap (USD): 5893369463.53125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0